Unnecessary meetings are the bane of the corporate world. Yet, despite what appears to be an overwhelming consensus that they’re often unnecessary and unproductive, many pharma and biotech companies continue to struggle to avoid them.
Does anyone at a big pharma company come into work thinking about ways to help people navigate complicated healthcare decision-making? They have lost track of who we serve and, more importantly, why.
QUICK READ: Throughout the country, employees are demanding a say in the way their companies do business because of social issues. Why haven’t we heard this type of corporate activism in healthcare?
KEY THOUGHT: Pharma companies three on meetings. According to an article in MIT’s Sloan Management Review, the average manager spends 23 hours a week in meetings, up a whopping 10 full hours (!) since the Mad Men era. Some of those meetings are no doubt productive but conservatively at least a third of the time spent on meetings is wasted in irrelevant conversations, boring presentations, and meandering chit-chat.
SUMMARY: No company can succeed without employees who care about customers. If pharma doesn’t make an effort to recruit and retain passionate, caring employees than they are in huge trouble.